IAIM
TEVA icon

International Assets Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

International Assets Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,935
Closed -$26K – 982
2023
Q1 		$26K Buy
+2,935
New +$29K ﹤0.01% 767
2021
Q2 		– Sell
-2,162
Closed -$23K – 1755
2021
Q1 		$23K Buy
2,162
+1,206
+126% +$13.8K ﹤0.01% 1262
2020
Q4 		$9K Buy
+956
New +$9.16K ﹤0.01% 1475

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

International Assets Investment Management's TEVA Position: Q2 2023 in Review

International Assets Investment Management sold out of Teva Pharmaceuticals (TEVA) in Q2 2023, closing a stake of 2,935 shares — an estimated $26K sold.

International Assets Investment Management first reported a position in TEVA in Q4 2020 and held it in 3 quarters. The position peaked at $26K in Q1 2023. 428 funds tracked by Wall St. Rank hold TEVA as of Q2 2023.

  • International Assets Investment Management reported no remaining Teva Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • International Assets Investment Management sold 2,935 Teva Pharmaceuticals shares in Q2 2023, an estimated $26K.
  • International Assets Investment Management first reported a position in Teva Pharmaceuticals in Q4 2020 and held it in 3 quarters.
  • International Assets Investment Management's Teva Pharmaceuticals position peaked at $26K in Q1 2023.
  • 428 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2023.

Based on International Assets Investment Management's 13F filing for Q2 2023, filed 20 Jul 2023.